Top section
Top section
Placement 3.7 times subscribed, weeks after regulator halted unauthorised marketing of a purported public offer
Markus Meier and Thore Zimmermann promoted
IPO pipeline strong, but timetables slipping as markets await clarity on tax, growth and defence funding
More articles
More articles
More articles
-
RBC Capital Markets has hired three women to its European global equity sales business at director level in London and Frankfurt. -
France’s IPO renaissance is expected to keep up the pace in the second half of the year, aided by the strong performance of French equities and a rebounding economy.
-
Hybrid electric vehicle maker Li Auto received the go ahead from Hong Kong’s stock exchange for a secondary listing.
-
SMBC has beefed up its coverage of the technology sector with the addition of two senior bankers in San Francisco who previously worked together at HSBC.
-
Hong Kong’s stock exchange has rejected an IPO application from Aim Vaccine, a leading Chinese vaccine maker. The deal is being sponsored by China Securities, CICC, Goldman Sachs and Macquarie.
-
Pharmaceutical ingredients manufacturer Glenmark Life Sciences is set to launch a Rp15.1bn ($202.6m) IPO on Tuesday.
Sub-sections
shared comment list
